Amgen, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:Amgen, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4428
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:68
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Amgen, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Amgen, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Amgen, Inc., (Amgen or ‘the company’) is a biotechnology company involved in the discovery, development, manufacture, and marketing of human therapeutics. The company has expertise in the areas of cancer, kidney disease, rheumatoid arthritis and other serious illnesses. Its product portfolio includes Prolia(denosumab), XGEVA(denosumab), EVENITY (romosozumab), Repatha (evolocumab), Aimovig (erenumab), Aranesp (darbepoetin alfa), BLINCYTO (blinatumomab), KYPROLIS(carfilzomib), Vectibix (panitumumab), Sensipar/Mimpara (cinacalcet), and AMJEVITA (adalimumab-atto)/AMGEVITA (biosimilar adalimumab). The company has business presence across the US,Europe, LatinAmerica, the Middle East and Asia-Pacific. Amgen is headquartered in Thousand Oaks, California, the US.

Scope

- Detailed information on Amgen, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Amgen, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Amgen, Inc. including a breakdown and examination of key business segments
- Intelligence on Amgen, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Amgen, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Amgen, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Amgen, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Amgen, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Amgen, Inc.: Company Overview 9
Amgen, Inc.: Overview and Key Facts 9
Amgen, Inc.: Overview 9
Amgen, Inc.: Key Facts 9
Amgen, Inc.: Key Employees 11
Amgen, Inc.: Key Employee Biographies 13
Amgen, Inc.: Major Products and Services 20
Amgen, Inc.: Company History 21
Amgen, Inc.: Management Statement 29
Amgen, Inc.: Locations and Subsidiaries 34
Amgen, Inc.: Key Competitors 36
Amgen, Inc.: Company Analysis 37
Amgen, Inc.: Business Description 37
Amgen, Inc.: SWOT Analysis 40
Amgen, Inc.: SWOT Overview 40
Amgen, Inc.: Strengths 40
Amgen, Inc.: Weaknesses 41
Amgen, Inc.: Opportunities 41
Amgen, Inc.: Threats 42
Amgen, Inc.: Corporate Financial Deals Activity 44
Amgen, Inc.: Financial Deals Overview 44
Amgen, Inc.: Targets and Partners 46
Amgen, Inc.: Top Deals 2014 – 2018YTD* 48
Amgen, Inc.: Advisors 49
Amgen, Inc.: Top Legal Advisors 49
Amgen, Inc.: Top Financial Advisors 49
Amgen, Inc.: Mergers and Acquisitions 51
Amgen, Inc.: Corporate Venturing 52
Amgen, Inc.: Capital Raising 53
Amgen, Inc.: Partnership 54
Amgen, Inc.: Divestments 55
Amgen, Inc.: Recent Developments 56
Amgen, Inc.: News and Events Summary 56
Amgen, Inc.: Business Expansion 61
Amgen, Inc.: Contracts 62
Amgen, Inc.: Corporate Governance 63
Amgen, Inc.: Financial Performance 64
Amgen, Inc.: Strategy and Operations 64
Appendix 66
Contact Us 66
Methodology 66
About MarketLine 67

List of Tables
Table 1: Amgen, Inc.: Key Facts
Table 2: Amgen, Inc.: Key Employees
Table 3: Amgen, Inc.: Locations and Subsidiaries
Table 4: Amgen, Inc.: Key Competitors
Table 5: Amgen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Amgen, Inc.: M&A Activity by Geography (TTM*)
Table 7: Amgen, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Amgen, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Amgen, Inc.: Targets and Partners
Table 10: Amgen, Inc.: Top Deals 2014 - 2018YTD*
Table 11: Amgen, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Amgen, Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Amgen, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: Amgen, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Table 15: Amgen, Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 16: Amgen, Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Table 17: Amgen, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 18: Amgen, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 19: Amgen, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 20: Amgen, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 21: Amgen, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 22: Amgen, Inc.: News and Events Summary
Table 23: Amgen, Inc.: Business Expansion
Table 24: Amgen, Inc.: Contracts
Table 25: Amgen, Inc.: Corporate Governance
Table 26: Amgen, Inc.: Financial Performance
Table 27: Amgen, Inc.: Strategy and Operations

List of Figures
Figure 1: Amgen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Amgen, Inc.: M&A Activity by Geography (TTM*)
Figure 3: Amgen, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Amgen, Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: Amgen, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Amgen, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Amgen, Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: Amgen, Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: Amgen, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 10: Amgen, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 11: Amgen, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 12: Amgen, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 13: Amgen, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Amgen, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Taseko Mines Limited:企業の戦略・SWOT・財務分析
    Taseko Mines Limited - Strategy, SWOT and Corporate Finance Report Summary Taseko Mines Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Innocoll AG (INNL)-医療機器分野:企業M&A・提携分析
    Summary Innocoll AG (Innocoll), formerly Innocoll Holdings Inc is a specialty pharmaceutical company that carries out the development and manufacturing of surgical implants and topically applied healthcare products in the areas of unmet clinical needs. The company’s pipeline product portfolio includ …
  • UniQure NV (QURE):企業の財務・戦略的SWOT分析
    UniQure NV (QURE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Coloplast A/S:戦略・SWOT・企業財務分析
    Coloplast A/S - Strategy, SWOT and Corporate Finance Report Summary Coloplast A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Confused.Com Limited:企業の戦略・SWOT・財務分析
    Confused.Com Limited - Strategy, SWOT and Corporate Finance Report Summary Confused.Com Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Principia Biopharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Principia Biopharma Inc (Principia Biopharma) is a clinical stage biopharmaceutical company that designs and develops oral small molecule drug therapies. The company’s proprietary Tailored Covalency technology helps to develop portfolio of drugs such as Bruton's tyrosine kinase inhibitor. It …
  • Majesco
    Majesco - Strategy, SWOT and Corporate Finance Report Summary Majesco - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Circassia Pharmaceuticals Plc (CIR):製薬・医療:M&Aディール及び事業提携情報
    Summary Circassia Pharmaceuticals plc (Circassia) develops and manufactures drugs for the treatment of allergy and respiratory diseases such as asthma. The company’s marketed products include Niox used to assist asthma management and Tudorza for the treatment of chronic obstructive pulmonary disease …
  • Daimler AG (DAI):電力:M&Aディール及び事業提携情報
    Summary Daimler AG (Daimler) is an automobile company that undertakes the manufacture, distribution and sales of premium passenger cars, commercial vehicles and related spare part and accessories. The company also provides services such as financing, leasing, fleet management, insurance, financial i …
  • BlackRock Inc:企業のM&A・事業提携・投資動向
    BlackRock Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BlackRock Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • STR Holdings, Inc.:企業の戦略的SWOT分析
    STR Holdings, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Bloomberg L.P.:戦略・SWOT・企業財務分析
    Bloomberg L.P. - Strategy, SWOT and Corporate Finance Report Summary Bloomberg L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Analog Devices, Inc.:企業の戦略・SWOT・財務情報
    Analog Devices, Inc. - Strategy, SWOT and Corporate Finance Report Summary Analog Devices, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Nayara Energy Ltd.:企業の戦略・SWOT・財務分析
    Nayara Energy Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nayara Energy Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Dynatronics Corp (DYNT)-医療機器分野:企業M&A・提携分析
    Summary Dynatronics Corp (Dynatronics) is a medical device company that offers rehab technology and equipment solutions. The company offers modalities, hot and cold therapy, clinical accessories, body positioning, sports medicine, orthopedics, hand therapy, strength equipment, treatment tables and r …
  • Pacific Biosciences of California Inc (PACB):企業の財務・戦略的SWOT分析
    Pacific Biosciences of California Inc (PACB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • The Tata Power Co Ltd:発電所・企業SWOT分析
    The Tata Power Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employe …
  • Julius Baer:企業のM&A・事業提携・投資動向
    Julius Baer - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Julius Baer Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Hitachi Zosen Corporation:企業の戦略・SWOT・財務分析
    Hitachi Zosen Corporation - Strategy, SWOT and Corporate Finance Report Summary Hitachi Zosen Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Alembic Pharmaceuticals Ltd (APLLTD):企業の財務・戦略的SWOT分析
    Summary Alembic Pharmaceuticals Ltd (APL) is a pharmaceutical company which manufactures and markets generic pharmaceutical products. The company’s active pharmaceutical ingredients include macrolides, NSAIDs, and other drugs. APL also offers branded formulations in the areas of antibiotics and anti …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆